Skip to main content

Table 7 KDQOL scale values among patients who returned a baseline assessment and at least one follow-up assessment

From: Impact of superimposed nephrological care to guidelines-directed management by primary care physicians of patients with stable chronic kidney disease: a randomized controlled trial

KDQOL scale

Time

Combined management (N = 62)

PCP management only (N = 60)

p

  

n

Value

n

Value

 

Symptoms

T0

62

70.0 (19.8)

60

70.6 (18.9)

0.87

T1

61

74.4 (16.7)

57

70.4 (19.0)

0.22

T2

50

72.7 (17.7)

49

72.2 (20.0)

0.90

Effects of kidney disease

T0

59

79.5 (21.7)

56

76.5 (19.4)

0.45

T1

59

81.4 (18.4)

51

75.7 (24.4)

0.17

T2

48

80.0 (18.8)

47

80.9 (19.4)

0.82

Burden of kidney disease

T0

59

70.8 (30.1)

60

63.2 (28.7)

0.16

T1

60

70.3 (31.1)

57

74.3 (28.3)

0.48

T2

50

68.2 (29.5)

47

70.2 (30.5)

0.74

Work status

T0

61

31.1 (31.8)

57

28.9 (34.0)

0.72

T1

58

28.4 (32.6)

53

25.5 (32.0)

0.63

T2

49

27.6 (33.9)

48

26.0 (32.6)

0.82

Cognitive function

T0

61

79.3 (24.2)

60

75.8 (22.5)

0.41

T1

60

76.2 (23.3)

56

75.7 (22.0)

0.92

T2

50

76.8 (23.6)

46

77.0 (23.9)

0.97

Quality of social interaction

T0

62

78.3 (18.1)

60

80.6 (18.2)

0.49

T1

61

78.0 (17.5)

57

78.1 (18.2)

0.98

T2

50

78.7 (18.7)

48

79.8 (16.6)

0.75

Sexual function

T0

25

54.5 (39.5)

23

62.5 (36.0)

0.47

T1

26

62.5 (37.9)

20

68.1 (39.6)

0.63

T2

18

66.7 (37.4)

13

70.2 (40.0)

0.80

  1. Continuous variables are expressed as mean (SD)
  2. T0, T1 and T2 represent baseline and follow-up at one and two years respectively